What is NDC 84696-200?

84696-200 is the product NDC for Komzifti (ziftomenib), Ziftomenib 200 mg/1 capsule, listed with the FDA by Kura Oncology, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

Kura Oncology, Inc., NDC labeler code 84696. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Komzifti?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Komzifti NDC 84696-200 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)84696-200Labeler and product segments. Claims need a package NDC.

Product NDC at billing width84696-0200Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
84696-200-90	84696020090	90 CAPSULE in 1 BOTTLE (84696-200-90)Marketed from Nov 13, 2025

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Komzifti
Generic name (nonproprietary): ziftomenib
Active ingredients: Ziftomenib — 200 mg/1
Dosage form: Capsule
Route: Oral
Labeler: Kura Oncology, Inc.NDC labeler code 84696
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 220305
Marketing start: Nov 13, 2025
Listing expires: Dec 31, 2026
Identifiers: Product ID 84696-200_3213879b-dd88-413b-9910-8fd422c99805SPL ID 3213879b-dd88-413b-9910-8fd422c99805SPL set ID b650f696-3391-4274-8b55-a5f5e9d04769RxCUI 2725990, 2725996UNII 4MOD1F4ENCUPC 0084696200906

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N484696020090 followed by a unit qualifier and the quantity

Package 84696-0200-90. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 9, 2025. This label includes a boxed warning.

Indications (excerpt from the label)

KOMZIFTI is indicated for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (AML) with a susceptible nucleophosmin 1 ( NPM1 ) mutation who have no satisfactory alternative treatment options [see Dosage and Administration ( 2.1 ), Clinical Pharmacology ( 12.1 ), and Clinical Studies ( 14 )] . KOMZIFTI is a menin inhibitor indicated for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (AML) with a susceptible nucleophosmin 1 ( NPM1 ) mutation who have no satisfactory alternative treatment options. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 84696-200

What is NDC 84696-200?: 84696-200 is the product NDC for Komzifti (ziftomenib), Ziftomenib 200 mg/1 capsule, listed with the FDA by Kura Oncology, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Komzifti (Ziftomenib).
What is the active ingredient?: Ziftomenib.
Who is the labeler?: Kura Oncology, Inc., NDC labeler code 84696. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Komzifti?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Komzifti (Ziftomenib) NDC 84696-200